Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat

Environmental Geochemistry and Health

Volumn 35, Issue 6, 2013, Pages 757-766

  Diacomanolis, Violet ^a   Noller, Barry N ^a   Ng, Jack C ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b University of South Australia and CRC for Contamination Assessment and Remediation of the Environment   (Australia)

Author keywords

Arsenic; Bioavailability; Interaction effect; Lead; Mine waste; Mixed contaminants; Pharmacokinetic parameters

Indexed keywords

ARSENIC; BIOACCUMULATION; BIOAVAILABILITY; LEAD; MINE WASTE; RISK ASSESSMENT; RODENT;

RATTUS;

ARSENATE SODIUM; ARSENIC ACID DERIVATIVE; LEAD ACETATE; ORGANOMETALLIC COMPOUND;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; AUSTRALIA; BIOAVAILABILITY; BLOOD; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; MASS SPECTROMETRY; METABOLISM; RAT; SOIL POLLUTANT; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; AREA UNDER CURVE; ARSENATES; AUSTRALIA; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; MASS SPECTROMETRY; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SOIL POLLUTANTS;

EID: 84886588594     PISSN: 02694042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10653-013-9527-x     Document Type: Article

References (41)

1. Agilent Technologies (2000). Application handbook. Agilent 7500 ICP-MS. Tokyo, Japan.
2. Agilent Technologies (2003). 7500 ICP-MS Chemstation and instrument training. Course number H8974A.
3. Ahsan, T., Zehra, K., Munshi, A., & Ahsan, S. (2009). Chronic arsenic poisoning. Journal of the Pakistan Medical Association, 59(2), 105-107.
4. Andrews, N. C. (2000). Intestinal iron absorption: Current concepts circa 2000. Digestive and Liver Disease, 32(1), 56-61.
5. Argos, M., Kalra, T., Rathouz, P. J., Chen, Y., Pierce, B., Parvez, F., et al. (2010). Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): A prospective cohort study. Lancet, 376(9737), 252-258.
6. Bruce, S. L. (2004). Development of a risk assessment tool to minimize the impact of arsenic and lead toxicity from mine tailling. PhD thesis, The University of Queensland, Brisbane.
7. Duggan, M. J., Inskip, M. J., Rundle, S. A., & Moorcroft, J. S. (1985). Lead in playground dust and on the hands of school children. Science of the Total Environment, 44, 65-79.
8. Gentry, P. R., Covington, T. R., Mann, S., Shipp, A. M., Yager, J. W., & Clewell, H. J. (2004). Physiologically based pharmacokinetic modeling of arsenic in the mouse. Journal of Toxicology and Environmental Health-Part A, 67(1), 43-71.
9. Gonzalez, M. J., Aguilar, M. V., & Para, M. C. M. (1995). Gastrointestinal absorption of inorganic arsenic (V)-the effect of concentration and interactions with phosphate and dichromate. Veterinary and Human Toxicology, 37(2), 131-136.
10. Hettiarachchi, G. M., Pierzynski, G. M., Oehme, F. W., Sonmez, O., & Ryan, J. A. (2003). Treatment of contaminated soil with phosphorus and manganese oxide reduces lead absorption by Sprague-Dawley rats. Journal of Environmental Quality, 32(4), 1335-1345.
11. Huston, R. E. (2005). Mixed metal/metalloid interactions affecting bioavailability with particular reference to mine tailling risk assessment. MPhil thesis, The University of Queensland, Brisbane.
12. Ilback, N. G., Glynn, A. W., Wikberg, L., Netzel, E., & Lindh, U. (2004). Metallothionein is induced and trace element balance changed in target organs of a common viral infection. Toxicology, 199(2-3), 241-250.
13. Johnson, L. R., & Farmer, J. G. (1991). Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure. Bulletin of Environmental Contamination and Toxicology, 46(1), 53-61.
14. Kapaj, S., Peterson, H., Liber, K., & Bhattacharya, P. (2006). Human health effects from chronic arsenic poisoning-a review. Journal of Environmental Science and Health, Part A, Toxic/Hazardouse Substances and Environmental Engineering, 41(10), 2399-2428.
15. Komarnicki, G. J. K. (2000). Tissue, sex and age specific accumulation of heavy metals (Zn, Cu, Pb, Cd) by populations of the mole (Talpa europaea L.) in a central urban area. Chemosphere, 41(10), 1593-1602.
16. Ludden, T. M., Beal, S. L., & Sheiner, L. B. (1994). Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection. Journal of Pharmacokinetics and Biopharmacutics, 22(5), 431-445.
17. Mann, S., Droz, P. O., & Vahter, M. (1996). A Physiologically based pharmacokinetic model for arsenic exposure: I. Development in hamsters and rabbits. Toxicology and Applied Pharmacology, 137(1), 8-22.
18. Marafante, E., & Vahter, M. (1987). Solubility, retention, and metabolism of intratracheally and orally-administered inorganic arsenic compounds in the hamster. Environmental Research, 42(1), 72-82.
19. Milton, A. H., Smith, W., Rahman, B., Hasan, Z., Kulsum, U., Dear, K., et al. (2005). Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology, 16(1), 82-86.
20. Naranmandura, H., Suzuki, N., Iwata, K., Hirano, S., & Suzuki, T. (2007). Arsenic metabolism and thioarsenicals in hamsters and Rrats. Chemical Research in Toxicology, 20(4), 616-624.
21. Naranmandura, H., Bu, N., Suzuki, K. T., Lou, Y., & Ogra, Y. (2010). Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats. Chemosphere, 81(2), 206-213.
22. Ng, J. C. (2005). Environmental contamination of arsenic and its toxicological impact on humans. Environmental Chemistry, 2(3), 146-160.
23. Ng, J. C., Seawright, A. A., Qi, L., Garnett, C. M., Chiswell, B., & Moore, M. R. (1999). Tumours in mice induced by exposure to sodium arsenate in drinking water. In R. Calderon, W. Chappel, & C. Abernathy (Eds.), Arsenic exposure and health effects (pp. 217-223). UK: Elsevier Science.
24. Ng, J. C., Wang, J., & Shraim, A. (2003). A global health problem caused by arsenic from natural sources. Chemosphere, 52(9), 1353-1359.
25. Owen, B. A. (1990). Literature-derived absorption coefficients for 39 chemicals via oral and inhalation routes of exposure. Regulatory Toxicology and Pharmacology, 11, 237-252.
26. Peakall, D., & Burger, J. (2003). Methodologies for assessing exposure to metals: speciation, bioavailability of metals, and ecological host factors. Ecotoxicology and Environmental Safety, 56(1), 110-121.
27. Preston, S., Coad, N., Townend, J., Killham, K., & Paton, G. I. (2000). Biosensing the acute toxicity of metal interactions: Are they additive, synergistic, or antagonistic? Environmental Toxicology and Chemistry, 19(3), 775-780.
28. Rees, M., Sansom, L., Rofe, A., Juhasz, A. L., Smith, E., Weber, J., et al. (2009). Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices. Environmental Geochemistry and Health, 31, 167-177.
29. Reeves, P. G., & Chaney, R. L. (2002). Nutritional status affects the absorption and whole-body and organ retention of cadmium in rats fed rice-based diets. Environmental Science and Technology, 36(12), 2684-2692.
30. Riethmuller, N., Markich, S. J., van Dam, R. A., & Parry, D. (2001). Effects of water hardness and alkalinity on the toxicity of uranium to a tropical freshwater hydra (Hydra viridissima). Biomarkers, 6(1), 45-51.
31. Scheckel, K. G., & Ryan, J. A. (2003). In vitro formation of pyromorphite via reaction of Pb sources with soft-drink phosphoric acid. Science of the Total Environment, 302(1-3), 253-265.
32. Suzuki, K. T., Katagiri, A., Sakuma, Y., Ogra, Y., & Ohmichi, M. (2004). Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicology and Applied Pharmacology, 198(3), 336-344.
33. Teijon, C., Del Socorro, J. M., Martin, J. A., Lozano, M., Bernardo, M. V., & Blanco, M. D. (2000). Lead accumulation in rats at nonacute doses and short periods of time: Hepatic, renal, and hematological effects. Ecotoxicology and Environmental Restoration, 3(1), 36-41.
34. Trenfield, M. A., McDonald, S., Kovacs, K., Lesher, E. K., Pringle, J. M., Markich, S. J., et al. (2011). Dissolved organic carbon reduces uranium bioavailability and toxicity. 1. Characterization of an aquatic fulvic acid and its complexation with uranium [VI]. Environmental Science and Technology, 45(7), 3075-3081.
35. Tsai, S.-Y., Chou, H.-Y., The, H.-W., Chen, C.-M., & Chen, C.-J. (2003). The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology, 24(4-5), 747-753.
36. Vahter, M., Marafante, E., & Dencker, L. (1983). Metabolism of arsenobetaine in mice, rats and rabbits. Science of the Total Environment, 30, 197-211.
37. Violante, A., & Pigna, M. (2002). Competitive sorption of arsenate and phosphate on different clay minerals and soils. Soil Science Society of America Journal, 66(6), 1788-1796.
38. Wright, R. O., Silverman, E. K., Schwartz, J., Tsaih, S. W., Senter, J., Sparrow, D., et al. (2004). Association between hemochromatosis genotype and lead exposure among elderly men: The normative aging study. Environmental Health Perspectives, 112(6), 746-750.
39. Yamaoka, K., Nakagawa, T., & Uno, T. (1978). Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Pharmacodynamics, 6(2), 165-175.
40. Yamauchi, H., Takahashi, K., & Yamamura, Y. (1986). Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster. Toxicology, 40(3), 237-246.
41. Zhang, Y., Huo, M., Zhou, J., & Xie, S. (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine, 99(3), 306-314.